Illumina, Cepheid Top Gainers in Down Month for GWDN Index | GenomeWeb

NEW YORK (GenomeWeb News) – Sparked by preliminary fourth-quarter revenue results that surpassed analysts' consensus estimate and the launch of its new HiSeq 2000 sequencer, shares of Illumina jumped roughly 20 percent in the month of January.

The firm's stock was the top gainer for the month, followed by Cepheid (+18 percent) and Caliper Life Sciences (+17 percent).

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.